Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis

Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis

ABSTRACT Although piperacillin-tazobactam (TZP) was shown to be less effective than carbapenems in treating bacteremia due to extended-spectrum β-lactamase-producing (ESBL)-producing organisms in a randomized controlled trial, the fact that many of the causative organisms co-produced inhibitor-resis...

Full description

Bibliographic Details
Main Authors: Kosuke Hoashi, Brian Hayama, Masahiro Suzuki, Aki Sakurai, Kazumi Takehana, Taisuke Enokida, Koichi Takeda, Daisuke Ohkushi, Yohei Doi, Sohei Harada
Format: Article
Language:English
Published: American Society for Microbiology 2022-08-01
Series:Microbiology Spectrum
Subjects:
ESBL
Escherichia coli
OXA-1
carbapenems
piperacillin-tazobactam
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02206-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.02206-22

Similar Items